奥雷辛-A通过调节下丘脑核中的神经活动来减弱运动恶心
Leilei Pan1, Shuifeng Xiao1, Zichao Xu1
1Department of Nautical Injury Prevention, Faculty of Navy Medicine, Naval Medical University (Second Military Medical University), Shanghai, China.
British journal of pharmacology
|December 22, 2023
概括
素-A的使用可以通过准特定的大脑区域和受体来缓解运动病. 鼻腔内氧素-A显示出作为一种新的运动恶心治疗方法的前景.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 运动性疾病是一种常见的神经系统疾病.
- 素系统在调节兴奋和自主功能方面发挥着作用.
- 中央奥雷克辛的应用对抗运动病的潜力尚未完全理解.
研究的目的:
- 为了调查中央素应用可以抵消运动恶心的假设.
- 为了识别与运动性 motion sickness 相关的 orexin-A 响应性大脑区域.
- 评估素-A及其对抗剂对大鼠和猫的运动恶心症状的疗效.
主要方法:
- 内脑内脑 (ICV) 的情况. 在被轮换的老鼠中注射素-A和OX1/OX2抗剂.
- 通过免疫标记来识别对素-A有反应的脑部区域.
- 在老鼠和猫的核内注射和鼻内注射素-A.
主要成果:
- 在老鼠的Orexin-A剂量取决于减弱的运动恶心行为 (厌食症,恶心,低活性,低温).
- 在下丘脑核 (DMV,PVN,PMV) 中的素A调节的Fos表达,具有与明显症状相关的特定核.
- 甲素-A和胺抑制了猫的吐;鼻内甲素-A对运动恶心症状显示出有效性.
结论:
- 素-A通过作用于下丘脑核中的OX1和OX2受体来缓解运动病.
- 针对特定大脑区域的素受体,为运动性疾病提供了潜在的治疗策略.
- 鼻内素-A是一种有前途的,非侵入性的方法来治疗运动恶心.
相关概念视频
01:15Equilibrium and Balance
4.7K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
4.7K
01:22Pathophysiology of Vomiting
467
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
467
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
178
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
178
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
332
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
332
01:24Sleep-Wake Cycles
1.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
298
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
298